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N-glycosylation plays a key role in the quality of many therapeutic glycoprotein biologics. The biosynthesis reactions of these
oligosaccharides are a type of network in which a relatively small number of enzymes give rise to a large number of N-glycans
as the reaction intermediates and terminal products. Multiple glycans appear on the glycoprotein molecules and give rise to
a heterogeneous product. Controlling the glycan distribution is critical to the quality control of the product. Understanding N-
glycan biosynthesis and the etiology of microheterogeneity would provide physiological insights, and facilitate cellular
engineering to enhance glycoprotein quality. We developed a mathematical model of glycan biosynthesis in the Golgi and
analyzed the various reaction variables on the resulting glycan distribution. The Golgi model was modeled as four
compartments in series. The mechanism of protein transport across the Golgi is still controversial. From the viewpoint of their
holding time distribution characteristics, the two main hypothesized mechanisms, vesicular transport and Golgi maturation
models, resemble four continuous mixing-tanks (4CSTR) and four plug-flow reactors (4PFR) in series, respectively. The two
hypotheses were modeled accordingly and compared. The intrinsic reaction kinetics were first evaluated using a batch (or
single PFR) reactor. A sufficient holding time is needed to produce terminally-processed glycans. Altering enzyme
concentrations has a complex effect on the final glycan distribution, as the changes often affect many reaction steps in the
network. Comparison of the glycan profiles predicted by the 4CSTR and 4PFR models points to the 4PFR system as more likely
to be the true mechanism. To assess whether glycan heterogeneity can be eliminated in the biosynthesis of biotherapeutics
the 4PFR model was further used to assess whether a homogeneous glycan profile can be created through metabolic
engineering. We demonstrate by the spatial localization of enzymes to specific compartments all terminally processed N-
glycans can be synthesized as homogeneous products with a sufficient holding time in the Golgi compartments. The model
developed may serve as a guide to future engineering of glycoproteins.
Citation: Hossler P, Mulukutla BC, Hu W-S (2007) Systems Analysis of N-Glycan Processing in Mammalian Cells. PLoS ONE 2(8): e713. doi:10.1371/
journal.pone.0000713
INTRODUCTION
Since the introduction of tissue plasminogen activator two decades
ago, many recombinant proteins produced by mammalian cells
have become important therapeutic biologics. A vast majority of
these recombinant proteins are glycoproteins. The extent of
glycosylation and the structure of the glycans on those glycopro-
teins have a profound effect on their biological activities and
circulatory half-life (for review see [1], [2]). Depending on their
attachment site on the polypeptide, these glycans are either
O-linked (through serine or threonine) or N-linked (through
asparagine on the Asn-X-Thr/Ser recognition sequence). N-
glycans in particular have an important role in protein folding in
the endoplasmic reticulum (ER). Unlike O-glycosylation, which
has been shown to initiate in either the ER or Golgi [3],
N-glycosylation is initiated by transfer of a preassembled oligo-
saccharide (Glc3Man9GlcNAc2) to Asn at the binding site of
a nascent protein translocating into the ER lumen [4]. Although
all N-glycans are linked to a protein molecule through Asn-X-
Thr/Ser, not all of these motifs are occupied by an N-glycan.
Hence, there exists different permutations of site occupancies in
proteins which frequently have multiple N-glycan binding sites.
This phenomenon is referred to as macroheterogeneity. Before
exiting the ER, three glucose, and usually at least one mannose
sugar are removed from the N-glycan. The removal of glucose
serves as a quality control for proper folding of these glycoproteins
and their readiness for transit to the Golgi apparatus [5].
Inside the Golgi, more mannose sugars are removed before
further extension of the glycan branches. Subsequent step-wise
addition of sugars to different positions of the extending glycan is
catalyzed by a number of glycosyltransferases, each adds
a particular monosaccharide through a specific glycosidic bond.
Most intermediate glycans along the biosynthetic pathway in the
Golgi have more than one available reaction site, either on the
same or different sugar moieties, for receiving a monosaccharide.
In some cases the reactions of adding those sugars to the glycan
may occur in different sequential orders. In others, the addition of
a particular glycosidic linkage hinders the reaction of the others [4].
Along the N-glycan biosynthesis pathway there are usually only
a relatively small number of glycosyltransferases each capable of
catalyzing different glycosidic linkages on different N-glycans, and
are used multiple times along the pathway. This web of reactions
forms a complex network which, when drawn out graphically,
indeed resembles a network of diverging and converging paths
leading to a number of different fully-extended N-glycan structures.
The glycans are thus rather diverse. Adding to this diversity, many
glycans do not achieve terminal processing, but exit with the
protein in the form of intermediately processed glycans.
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categories: high mannose, complex and hybrid types. All of them
share a common tri-mannosyl (Man3GlcNAc2) core structure. The
high mannose glycans have 5 to 9 mannose (Man5–9GlcNAc2)
sugars. Those with 2 GlcNAc’s attached to the tri-mannosyl core
are called complex type. As its name implies, the hybrid type are
a combination of high mannose and complex glycans, and have at
least three mannose sugars, but only one GlcNAc on one
nonreducing mannose. This diversity of glycan sugar composition
on each glycosylation site is referred to as microheterogeneity.
N-glycan microheterogeneity thus arises through enzyme pro-
cessing in the Golgi apparatus. The Golgi apparatus is consisted of
stacks of membranous compartments commonly grouped into cis,
medial, trans, and TGN (trans-Golgi network) cisternae. These
cisternae are not biochemically homogeneous. As the secretory
glycoproteins traverse through these Golgi compartments the
glycan extension reactions are catalyzed by varying compositions
of glycosylation enzymes in each compartment. There are still
unresolved questions on the nature of Golgi compartmentalization
and different models on intra-Golgi transport have been proposed
[6,7]. In the vesicular transport model the different stacks of
cisternae (or compartments) are seen as stationary while the
secretory cargo is transported by vesicles which bud off one stack
and fuse to the next. In contrast, the Golgi maturation model
envisions the secretory cargo as being relatively stationary with
respect to the stack or compartment in which they reside; while
each compartment undergoes a maturation process to transform
from early cisternae to late cisternae. Although recent visualization
studies on yeast seem to favor the maturation model [8,9], the
controversy persists [10].
From a classical reaction engineering perspective the two
models present two different idealized reactor scenarios. The
vesicular transport model resembles a model of continuous stirred
tank reactors in series (CSTR’s). The glycoprotein molecules enter
the first compartment and after a finite amount of holding time
they are continuously transported to the next one downstream.
Conversely, protein processing in the Golgi maturation model is
better represented by a non-stationary batch reactor. The reactor
thus closely resembles a plug-flow reactor (PFR), the traversal of
protein over time in the maturation model can be viewed in the
same way as traveling downstream in a tubular reactor. A key
distinction between the two models is that in the maturation model
all protein molecules entering the Golgi together will exit at the
same time, while in the vesicular transport model, mixing in each
compartment facilitates different protein molecules residing in
each compartment for different lengths of time. Common to both
models is that the enzyme composition varies as the glycans
proceed downstream. Since the time each protein molecule spends
in the Golgi compartments affects the extent of glycan extension,
the distribution of residence times will have a profound effect on
their N-glycan structure.
The microheterogeneity of N-glycans on glycoproteins can
thus be attributed to the nature of the glycosylation reactions
and the mixing characteristics of the Golgi apparatus as proteins
traverse the system. With the clinical importance of glycoprotein
therapeutics, there is a strong desire to better control the
variability of glycoforms of those products. A better understanding
of kinetics of the reactions involved and the maturation process of
Golgi apparatus will certainly aid in the control of microhetero-
geneity of glycoprotein products. However, with the reaction
kinetic parameters difficult to determine experimentally, and with
the model of Golgi processing still being debated, experimental
assessment of the source of microheterogeneity and exploration of
their control is difficult. An alternative to experimental in-
vestigation is through mathematical modeling to assess the
effectiveness of metabolic intervention towards the channeling of
glycans under different models.
Previous studies have applied mathematical models to evaluate
protein N-glycosylation microheterogeneity [11,12]. Those two
studies modeled the Golgi as four continuous well-mixed reactors
in series. In light of recent experimental evidence that favors the
maturation model [8,13], we evaluated the differences between
different reactor characteristics on the resulting glycan distribu-
tion. This work presents the simulation results through a visuali-
zation tool we have previously reported [14] to allow for quick
assessment of the effects of various parameters (see Table S1 in the
Supporting Information) on the glycan flux distribution.
MATERIALS AND METHODS
System Description
The model of N-glycosylation considers the core N-glycan
biosynthetic pathway in the Golgi apparatus common to most
host cells used for the expression of recombinant proteins. The
pathway consists of a large number of reactions catalyzed by
a relatively small number of enzymes. The ability of many of these
enzymes to catalyze the same reaction on different glycan
substrates, and the fact that most glycans can possibly be
a substrate of more than one enzyme, makes this pathway form
a highly branched, initially divergent, and eventually convergent
network. Since the model considers glycosylation reactions in the
Golgi, the input into the system is considered to be a 9-mannose
glycan on a single Asn-x-Thr/Ser glycosylation site that can be
processed in the Golgi.
The N-glycosylation enzymes considered in this model are
shown in Table 1. The substrate specificities and their glycan
intermediates and products have been described previously [14].
There exist a large number of pathways connecting the respective
glycans towards the initial 9 mannose glycan that we consider to
be the root of the biosynthetic tree (Fig. 1A). Figure 1B shows
a pathway representation of this initial N-glycan (glycan 1)
entering the pathway with that of the twelve fully processed N-
glycans considered in this model, and discussed more extensively
in the subsequent sections. Least processed N-glycans are
considered to be the non-terminally processed, high mannose,
hybrid, and incompletely processed biantennary glycans, early N-
glycans include terminally processed biantennary glycans as well as
non-fully galactosylated tri- and tetraantennary glycans, and late
N-glycans are considered to be the more fully galactosylated tri-
and tetraantennary glycans. Figure 1C highlights the glycosidic
linkages of some of these glycans to serve as a reference.
The model considers glycosylation reactions occurring in four
compartments of equal volume in series, representing the cis,
medial, trans, and trans-Golgi network (TGN) compartments.
Inter-compartmental transport of glycosylated protein molecules is
limited to adjacent compartments via retrograde and anterrograde
transport. The glycoprotein is transferred from the ER into the
first compartment. From each subsequent compartment the
glycans are transferred to the next, eventually being secreted from
the last compartment in an anterrograde manner. The volume of
each compartment is assumed to be constant; implicitly balanced
by anterrograde transport from the upstream compartment. For
simplification, no retrograde transport or the reverse flow of the
glycoprotein is considered. The holding time for glycoproteins in
each compartment is set to be the same. A schematic of the Golgi
system is shown in Figure 2.
The enzyme composition in each compartment may differ as
reported [15]. The mixing behavior of the enzymes and glycans
N-Glycan Processing
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affects the glycan profile. The enzymes within each compartment
are considered to be uniformly distributed and their concentra-
tions at steady state. The distribution of the N-glycans (and the
protein molecules they are conjugated to) in each compartment is
modeled as that of either well-mixed reactor (CSTR), or a plug
flow reactor (PFR) as discussed in the Introduction section. It is
assumed that anterrograde transport is non-selective, thus in the
CSTR model all glycoproteins in a particular compartment can be
transported. In contrast, in the PFR model, only those
glycoproteins that have reached the distal end of the compartment
are transported. In this context, the well-mixed model is
a representation of the vesicular transport model in which the
glycoprotein molecules traversing through the four compartments
have a distribution of residence times which is dictated by the
mixing characteristics of the Golgi. Whereas the PFR model
represents the maturation model, in which all glycoprotein
molecules are confined to the same physical entity until secretion.
Mass balances on the N-glycan species for each of the
compartments in the CSTR model give the following:
dC
n
dt
~SR
nzC
n{1f
n{1,nzC
nz1fnz1,n{C
nfn,nz1{
C
nfn,n{1
ðEq:1Þ
Where superscript n denotes the compartment n, C is the
concentration vector for the N-glycans, and S is the stoichiometric
matrix. R is the reaction rate vector dependent on both kinetic
constant values, and the concentration of glycan and nucleotide-
sugar substrates. The last four terms on the right hand side of Eq. 1
describes the anterrograde and retrograde transport of glycans
between compartments n, n-1, and n+1. In the CSTR model all
glycoprotein molecules are transported at a constant rate f. The
balance of these transport terms keeps the volume of each
compartment constant.
In the PFR model both space and time are independent
variables as shown below,
LC
n
Lt
~   v
LC
n
Lz
zD
L
2C
n
Lz2 zSR
n ðEq:2Þ
where v is the linear velocity. In the case of the Golgi maturation
model, all the protein molecules are held in the same cisternae for
N-glycan processing, and the dispersion of the molecules is
Figure 1. Glycan reaction network and its symbolic representation. A:
Schematic of the formation of the terminally processed N-glycans;
dashed lines denote multiple reaction steps. B: The corresponding
network representing the various pathways connecting the glycans
shown in A; least, early, late, and terminally processed glycans denoted
on the network, as plotted by GlycoVis. C: The starting glycan and the
most fully processed N-glycan considered in the model, with sugar
linkages labeled for reference.
doi:10.1371/journal.pone.0000713.g001
Table 1. List of enzymes considered with their reported and calculated parameter values.
..................................................................................................................................................
Enzyme (em) rmax
em (mM/min/cell) cem (mM) k
cat
em (min
21) Reference MWem Reference
Man I 611 19.9 30.1 [17] 230,000 [18]
Man II 5797 6.6 883.7 [18] 285,000 [19]
GnT I 1358 1.7 790 [20] 46,500 [21]
GnT II 671 0.5 1314 [22] 43,000 [23]
GnT III 12 0.2 56 [24] 114,000 [25]
GnT IV 29 0.3 94 [26] 63,200 [26]
GnT V 2637 2.2 1188 [27] 69,000 [27]
FucT 2969 15.4 192 [28] 44,000 [29]
GalT 1235 80.2 15 [30] 440,000 [31]
SiaT 2328 1.6 1502 [32] 40,500 [33]
doi:10.1371/journal.pone.0000713.t001
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PLoS ONE | www.plosone.org 3 August 2007 | Issue 8 | e713assumed to be negligible. The transport between adjacent
compartments is described by boundary conditions at the entrance
(z=0) and exit (z=l) of the compartment. At z=0,
C
n~C
n
z~0 for n~1
C
n~C
n{1
z~1 for n~2,3,4
where C
n{1
z~1 are the vector of glycan concentrations at the exit of
the previous compartment, and C
n
z~0 are the vector of glycan
concentrations entering the system. At steady state, when the
concentration profiles of all glycans are well-established in the
reactor, the equation becomes
v
dC
n
dz
~SR
n ðEq:3Þ
For both the CSTR and PFR models the anterrograde transport
from the ER into the cis compartment is assumed to include only
the initial 9-mannose glycan attached to the glycoprotein as input
into the entire system. Unless specified, it is assumed that the
amount of glycoproteins contributed from retrograde transport in
the other compartments is negligible.
Enzyme Kinetics
Among the ten enzymes considered, two (Man I and Man II)
exoglycosidase enzymes use glycans as their sole substrate, while the
other eight (GnT I-V, FucT, GalT, SiaT) glycosyltransferases use
both N-glycans and the corresponding nucleotide-sugar as sub-
strates. The one substrate enzymes were considered to follow
Michaelis-Menten kinetics with substrate competition. The two
substrate enzymes were assumed to follow a rapid equilibrium,
random, bi-bi mechanism. Each of the glycosyltransferases can add
a monosaccharide to multiple glycans through the formation of
a specific glycosidic bond. Those glycans are treated as competing
substrates. For the one substrate enzymes, the equation for the p
th
reaction catalyzed by enzyme em in compartment n is expressed as:
rp~
rmax
em cn
gi
KG
em 1z
P z
k~1
cn
gk
KG
em
   ðEq:4Þ
Similarly, for the two substrate enzymes:
rp~
rmax
em cn
gicn
sj
KS
emKG
em 1z
P z
k~1
cn
gk
KG
em
z
cn
sj
KS
em
z
P z
k~1
cn
gkcn
sj
KG
emKS
em
   ðEq:5Þ
In both equations, gi is any glycan which can be a substrate of em,
and in the case of the latter, sj refers to the corresponding nucleotide-
sugar (see Text S1 in the Supporting Information). The two
summation terms in the denominator of Eq. 5 take into
consideration the competitive inhibition of N-glycan substrates
towards the enzymes, which reduce the individual reaction rates.
The enzymes that react upon the N-glycans towards the terminal
stages of processing (GalT, SiaT) have the largest number of
potential substrates (Table 2). As a result, the denominator term is
quite large for these enzymes.
Parameter Values
The concentrations and rmax
em values of the enzymes involved in
glycan biosynthesis vary widely among different cell lines. The
rmax
em values and enzyme concentrations that have been reported in
the literature for the enzymes considered are listed in Table 1 [16-
32]. These values were estimated from maximum reaction rates
and enzyme concentrations reported for each enzyme in the
Figure 2. Schematic of the Golgi as a system of four reactors in series.
doi:10.1371/journal.pone.0000713.g002
Table 2. List of KG
emand KS
em values used in the model.
......................................................................
Enzyme (em)
# of Glycan
Substrates KG
em (mM) KS
em (mM) Reference
Man I 8 17 N/A [17]
Man II 6 200 N/A [35]
GnT I 1 260 170 [36]
GnT II 7 190 960 [22]
GnT III 7 21 420 [24]
GnT IV 13 800 220 [26]
GnT V 12 87 11000 [27]
FucT 11 25 46 [28]
GalT 232 660 22 [30]
SiaT 234 67 28 [37]
doi:10.1371/journal.pone.0000713.t002
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PLoS ONE | www.plosone.org 4 August 2007 | Issue 8 | e713literature, assuming a total cellular protein content of
250610
29 mg per cell (see Text S2,S3 in the Supporting
Information). It was further assumed that the volume of each
Golgi compartment (V) was equal to 10
-13 ml, as estimated using
electron microscopy of Golgi cisternae [33]. In the cases that
multiple glycan reactants are substrates for the same enzyme, the
KG
em values were assumed to be equal for each glycan (Table 2)
[16,21,23,25-27,29,34-36].
Unless specified otherwise, 186 molecules/s of glycoprotein was
used as the rate of input from the ER into the Golgi. This number
was chosen as it corresponds to a productivity of 40 pg/cell/day of
protein (MW 150 kDa), a level commonly seen in highly secretory
cells, and possibly closer to the levels in the types of cells reported
in the literature [37] from which the enzyme concentrations and
kinetic constants were used. Each molecule is assumed to have one
glycosylation site. The mean residence time of a protein molecule
(as well as the glycan) in each compartment is assumed to be
10 min. The vesicular transport rate is 10
214 ml/min unless
specified otherwise.
The ten enzymes were considered to have a spatial localization
across the Golgi cisternae. The mannosidases are generally localized
towards the cis/medial regions of the Golgi, the N-acetylglucosami-
nyltransferases and fucosyltransferases are localized towards the
medial region, and the galactosyltransferases and sialyltransferases
are localized towards the trans and trans-Golgi network (TGN)
regions of the Golgi.In ourmodel,unlessotherwise specified,Man I-
II are assumed to be localized in the four compartments in a [0.15,
0.40, 0.30, 0.15] ratio; GnT I-V were localized in a [0.20, 0.45, 0.20,
0.15] ratio; and GalT and SiaT in a [0, 0.05, 0.20, 0.75] ratio [38].
The intra-Golgi concentration of nucleotide-sugars has been
reported to be in the mM range, at levels, 10–50 fold higher than
that in the cytosol [39,40]. Unless specified otherwise, the
concentration of each individual nucleotide-sugar is assumed to be
the same in all of the compartments.
Model Simulation and Parameter Estimation
The model equations were solved in Matlab (Mathworks, Inc.)
using an implicit ODE solver. The initial glycan concentrations
were all assumed to be zero, except the first initial 9 mannose
glycan, whose concentration was set equal to the total protein
concentration. All calculated solutions were stable steady states
with negative, real eigenvalues. The simulation results are
displayed through a pathway visualization program, GlycoVis
[14]. Representative pathway maps for the system are shown in
Figure 3, where the reactions catalyzed by each of the 10 enzymes
are highlighted using a different color.
An objective of this study was to gain insight on the effects of
different variables on the resulting glycan distribution. We sought
to obtain a set of parameter values for which all the terminally
processed glycans are well represented in the product mixture, so
that any perturbation introduced can be better seen. While
keeping the kinetic parameters constant (i.e., k
cat
em , KG
em, and KS
em
values), we identified a set of enzyme and nucleotide-sugar
concentrations that allow for a relatively even distribution of the
twelve terminally processed N-glycans.
The method of steepest descent in a Matlab program was used
to adjust the enzyme and nucleotide-sugar concentrations that give
rise to a mixture of terminal glycans of a specified pattern.
Specifically, in the initial evaluation of the model the enzyme and
nucleotide-sugar concentrations that produce the terminal glycans
in the same order of magnitude were used as listed in Table 3.
Later in the study the method was applied to search conditions
that will produce a single terminal N-glycan. The objective
function that was minimized is shown in Eq. 6, where cn
gi,predicted is
the concentration of glycan species gi in compartment n predicted
at each iteration of the solver, and cn
gi,setpoint is the desired value.
F~
P 341
i~1
cn
gi,predicted cn
gi,setpoint
   2
ðEq:6Þ
The enzyme and nucleotide-sugar concentrations obtained were
values of a local minimum of the objective function, not a global
minimum. Nevertheless, these values enable us to better discern
the changes of various fluxes under different simulation conditions.
Sensitivity Analysis
The degree to which an enzyme controls metabolic pathway fluxes
can be represented by sensitivity coefficients for fluxes,
dJ,i~
cem
Jcgi
LJcgi
Lcem
ðEq:7Þ
where Jcgi is the flux of the N-glycan exiting the Golgi. Positive
sensitivity coefficients indicate a direct relationship between
Figure 3. Pathway maps with reactions highlighted according to the
enzyme catalyzing the reaction.
doi:10.1371/journal.pone.0000713.g003
N-Glycan Processing
PLoS ONE | www.plosone.org 5 August 2007 | Issue 8 | e713changes in enzyme levels with that of the exiting fluxes. Negative
coefficients indicate an inverse relationship. Sensitivity analysis can
also be taken with respect to other variables such as nucleotide-
sugar concentrations.
RESULTS
Glycan Processing in a PFR Model
Effect of processing time The model we have constructed is
a generic one with most enzymes commonly seen in rodent and
human cells in culture. However, the relative abundance levels of
these enzymes vary amongst different cell lines. Instead of focusing
on simulations for a particular cell line, we employ the model to
illustrate key features of the glycosylation system that gives rise to
glycan microheterogeneity and affects the glycoprotein quality.
With the parameter values used, a holding time of 40 minutes is
sufficient to allow all glycans to reach the terminal glycans in every
branch. To probe the kinetic behavior of the glycosylation system,
we examined the system operating like an ideal plug flow reactor
with a normalized distance from entry of 1, (i.e., time divided by
40 minutes) sufficiently long for a complete conversion of all
glycans to the terminally processed glycans. The initial 9-mannose
glycan that enters the compartment reacts to form intermediate
glycans as it moves downstream. At different time points after its
entry (corresponding to a fixed position downstream from the
entry point along the Golgi system), a snapshot of the
concentration profile of all glycans, and the flux of every
reaction was taken. The enzyme and nucleotide-sugar
concentrations used were obtained from nonlinear optimization,
as explained in the Model section, and are listed in Table 3 for the
results shown in Figure 4. They were further assumed to be
uniform throughout the compartment in order to better discern
the effects of residence time. The reaction rates at different points
in the compartment are affected only by the glycan.
The twelve terminally processed N-glycans at different time
points after the initial glycan enters the Golgi are shown in
Figure 5. As time progresses the concentration of most terminally
processed glycans increase. After 40 min of processing all of the
initial glycan input has reached the terminal glycans. Using the
visualization program GlycoVis, the concentrations of every
glycan in the network, as well as the flux of each particular
reaction at 10, 20, and 40 minutes were visualized as shown in
Figure 6. As the glycans move downstream in the Golgi, more
complex glycans begin to appear. But at any given position
a heterogeneous mixture of glycans is present. Given sufficient
time all glycans can reach terminal processing and the number of
glycans converges to twelve. As described in materials and method
the enzyme concentration needed in the simulation was adjusted
to give a flux profile of all terminal glycans in the same order of
magnitude. The flux distribution plot (Fig. 6B,D,F) demonstrates
that the reactions involved in final glycan extension are less active
in the front end of the Golgi (Fig. 6B), while the early glycan
processing reactions are less active in the distal end of the Golgi
(Fig. 6F). However, many enzymes catalyze multiple reactions in
the network and are utilized more uniformly throughout,
catalyzing reactions involving different glycan substrates in
different parts of the Golgi.
Effect of pathway branching on glycan microhetero-
geneity In a reaction system with branched pathways, like the
protein N-glycosylation pathway, the branch points determine the
distribution of fluxes and are the controlling points where fluxes
can be directed towards a particular product. However, the
glycosylation reaction system is a complex system with an
extensive substrate spectra for many of the enzymes involved.
Table 3. Enzyme and nucleotide-sugar concentrations
calculated through nonlinear optimization.
......................................................................
Enzyme (em) rmax
em (mM/min/cell) cem (mM)
Man I 920 29.7
Man II 1220 1.4
GnT I 950 1.2
GnT II 1893 1.4
GnT III 165 2.9
GnT IV 809 8.6
GnT V 1020 0.9
FucT 322 1.7
GalT 345 23
SiaT 710 0.5
Nucleotide-Sugar (sj) csj (mM)
GDP-Fuc 4910
UDP-GlcNAc 1440
UDP-Gal 5030
CMP-Sia 5000
doi:10.1371/journal.pone.0000713.t003
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Figure 4. Percentage of the terminally processed N-glycans after
adjusting the enzyme levels in a single PFR model (dashed line
corresponds to a completely equal mixture).
doi:10.1371/journal.pone.0000713.g004
Figure 5. Effect of normalized distance (holding time) on glycan flux
in a PFR model.
doi:10.1371/journal.pone.0000713.g005
N-Glycan Processing
PLoS ONE | www.plosone.org 6 August 2007 | Issue 8 | e713Except for GnT I, which reacts upon only one glycan, and Man I
which reacts upon the earliest high mannose glycans, the other
enzymes are involved in multiple branches of the pathway. In fact,
these eight enzymes generated 326 glycans in the pathway. Many
enzymes involved in a reaction at a particular branch point are
also involved in other downstream reactions in the same, and/or
different branches. Channeling the flux at a branch point by
amplifying the enzyme involved, or by suppressing another
enzyme catalyzing a competing reaction, will invariably cause
changes in other downstream reactions. The end results thus may
not be as expected.
To assess the effect of different enzyme levels on the resulting N-
glycan profile, sensitivity coefficients of the 12 terminally processed
glycans were calculated with respect to the 10 enzymes after
40 minutes; sufficiently long for all reactions to complete (Fig. 7).
As expected, changing the level of any particular enzyme, except
SiaT, had a rather profound effect on the terminal glycan flux.
Most enzymes had a strong effect on multiple branches in the
pathway. It is noted that even Man I and Man II, the two enzymes
catalyzing the initial reactions prior to the glycan extension
reactions, also had a rather profound influence on terminal glycan
composition. Upon closer examination, this is attributed to the
effect of their reaction rate on the downstream concentrations of
glycans at branch points. Altering the glycan concentration at the
branching nodes has an effect on the ratio of fluxes diverging from
the branch point because of differences in rmax
em and KG
em values of
these different enzymes for the same glycan substrate. The fact
that no single, terminally processed glycan has a prevailing positive
sensitivity coefficient suggests that upon changing the level of an
individual enzyme, more than one glycan will be affected.
Figure 6. Visualization of the glycan profile and relative reaction rates as a function of normalized distance. A,B: 0.25 C,D: 0.50 E,F: 1.0
doi:10.1371/journal.pone.0000713.g006
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which gives a high sensitivity coefficient for the flux of glycan 20.
One glycan substrate of GalT, glycan 11, is positioned at a pivotal
branch point of the network. Besides accepting Gal to its b(1,2)
GlcNAc to form glycan 318 (as shown in Fig. 8C), it can also add
GlcNAc to its a(1,6) Man through GnT II forming glycan 12.
However, the addition of galactose to glycan 11 lowers the
selectivity of the glycan for GnT II, thus committing the glycan
towards the formation of hybrid type glycans [4]. This branch
point thus affects the ratio of complex and hybrid type glycans on
the glycoprotein. Increasing the level of GalT increases the flux
towards glycan 318, and downstream glycan 20. The simulation
results of the glycoform distribution after 40 minutes are
compared between the base case GalT enzyme concentration
with that of a 10-fold increase in GalT concentration (Fig. 8A,B).
The fluxes around this branching point are also shown (Fig. 8C,D).
As shown in Figure 8D, their rates change as the glycoproteins
move downstream in the compartment. To better illustrate those
fluxes around this pivotal point, their dynamics along the Golgi is
shown. The fluxes for all of the reactions are initially low and
gradually rise. This is expected near the beginning since the
substrates have not yet been formed. However, after reaching
a high activity region it sustains for some duration before subsiding
again. Note that the relative magnitude of the fluxes catalyzed by
GalT and GnT II differ quite a bit upon increasing GalT by 10-
fold. Nevertheless, the flux to complex glycan 12 is not zero. It is
readily seen how the ratio of fluxes towards glycans 12 and 318
decreased as a result of this perturbation (Fig. 8E). It should be
kept in mind that an important variable not considered in this one
compartment model is enzyme localization. One would expect
that localization would have an important role towards ensuring
that glycan 20, and other less commonly observed hybrid type
glycans, are not measured in abundance.
The results shown in Figure 8 demonstrate that increasing GalT
by ten-fold does channel most of the flux towards hybrid type
glycan 318, and away from complex type glycan 12. However,
GalT reacts with 231 other N-glycans as can be seen in Figure 3 in
addition to glycan 11. Increasing GalT concentration affects all
Figure 7. Sensitivity coefficients of the 12 terminal glycans with respect to the ten enzymes.
doi:10.1371/journal.pone.0000713.g007
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but also in other GalT catalyzed reactions (Fig. 8F). In addition, as
can be seen from the kinetic expression in Eq. 5, even though the
concentration of those competing substrates may be low, their
combined effect may be profound on the resulting galactosylation
of glycan 11.
Channeling glycans to reduce microheterogeneity To
evaluate the feasibility of redirecting the fluxes to near structural
uniformity by metabolic engineering, nonlinear optimization was
applied with enzyme levels as adjustable variables. Using the
nonlinear optimization algorithm we explored the possibility of
altering enzyme concentrations to direct the fluxes to a single
terminal glycan. The abundance level attainable for each one of
the 12 terminal N-glycans, and the percentage of the other
terminal glycans along with the levels of each enzyme are shown as
a column in Table 4. For some terminal glycans, a very high level
of uniformity (glycans 26, 325 and 336) can be achieved. However,
for others (glycans 99, 315), a high abundance level is not
attainable. A particular example worth noting is channeling fluxes
to glycan 315, a fully sialylated, and tetraantennary glycan. Its
percentage of the total N-glycan profile did not exceed 85% even
upon major changes in enzyme levels. As illustrated in Figure 9, at
a key branch point, GnT III, GnT IV, GnT V, and GalT all
compete for the same substrate glycan 15. GnT III, GnT IV and
GnT V add an N-acetylglucosamine to glycan 15 to three different
positions. Ostensibly their reactions may occur in different orders,
but will eventually give rise to the same glycan, although through
different intermediates; and even lead to the same final glycan 315.
However, once GnT III reacts upon glycan 15 (giving rise to
glycan 46), GnT IV and GnT V have a lower specificity towards it;
and once GalT reacts upon glycan 15 (transforming it to glycans
19 or 48), GnT III has a lower specificity toward it. GalT and
GnT III reactions on glycan 15 thus lead to the diversion of glycan
extension reactions away from glycan 315. To maximize glycan
315 formation, GnT IV and GnT V enzyme levels need to be
sufficiently high to compete against GalT and GnT III, whose
levels must be comparatively smaller, as seen in Table 4. Ideally
one would eliminate GnT III and GalT to block the two branches
Figure 8. The effect of GalT amplification on N-glycan fluxes. A: Terminal glycan fluxes with basecase GalT concentration. B: Terminal glycan fluxes
with 10X higher GalT concentration. C: Controlling branch point in N-glycan biosynthesis. D: Comparison of fluxes at branch point shown in C, at
different GalT concentrations, and normalized distances. E: Ratio of fluxes at the branch point, at different GalT concentrations. F: Fluxes of all GalT
catalyzed reactions, at different GalT concentrations and normalized distances.
doi:10.1371/journal.pone.0000713.g008
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downstream reactions along the branches catalyzed by GnT IV
and GnT V to lead to glycan 315. Eliminating those diverting
branches will thus also abrogate the synthesis of glycan 315.
Therefore, manipulation of enzyme levels alone will not direct
most of the fluxes to glycan 315. Another alternative would be to
control the order at which these enzymes react upon glycan 15.
Effect of compartmentalization and enzyme spatial
localization The simulations shown above are based on
uniform flow and assume the Golgi apparatus behaves as a single
compartment. With the PFR assumption whether the Golgi is
treated as a single compartment or multiple compartments in
series the reaction characteristics are the same. However, with
different enzyme distributions in the four compartments, the
reaction kinetics will be different from those of single
compartment. To assess the effect of a spatial distribution of
enzymes, a simulation was performed using the same set of
parameters as those used for the results shown in Figure 4. Each of
the four PFR has a normalized distance of 0.25 or a holding time
of ten minutes. The distribution of enzymes in the four
compartments was described in the Parameter Values section.
Within each compartment the enzymes are assumed to be
uniformly distributed. For comparison, the simulation results of
the 1PFR and 4PFR models are both shown in Figure 10. The
most significant effect of spatial distribution of enzymes is
a decrease in flux for most of the terminal glycans and the
emergence of non-terminal glycans (Fig. 10A,B respectively). The
representation of upstream enzymes is reduced in later Golgi
compartments. As a result, the early glycans which are relatively
‘‘under-processed’’ in the early compartment will be even more
likely to remain unprocessed and appear in the final product.
Glycan Processing In A Well-mixed,
Compartmentalized Model
The simulations performed with varying residence times in the
plug flow model demonstrated that an insufficient holding time
can lead to incomplete processing. The glycoform profiles
Figure 9. Competing reactions utilizing glycan 15.
doi:10.1371/journal.pone.0000713.g009
Table 4. Enzyme concentrations sufficient to achieve a high percentage of each terminal N-glycan.
..................................................................................................................................................
Enzyme (em) Enyzme Concentration
a Ce1(mM) ðÞ
Man I (29.7) 11.4 183.8 53.4 384.0 139.7 16.7 74.8 318.8 34.6 40.7 271.0 168.9
Man II (1.4) 2.5 9.3 6.9 6.8 7.1 6.6 6.8 8.4 6.6 5.4 39.6 12.7
GnT I (1.2) 0.6 3.6 1.3 1.7 2.1 1.4 6.3 6.3 2.2 8.7 5.4 4.1
GnT II (1.4) 2.9 7.1 5.4 4.6 6.8 5.3 5.7 6.5 0.7 38.0 38.1 38.1
GnT III (2.9) 0.0 0.0 0.0 332.1 16.8 3.3 0.0 14.2 0.0 9.8 0.0 94.3
GnT IV (8.6) 77.2 0.0 0.0 7.8 0.0 0.0 49.6 92.8 32.5 119.6 1.6 1.6
GnT V (0.9) 1.3 0.0 8.2 2.2 0.0 4.0 0.0 0.0 3.4 8.9 0.1 0.1
FucT (1.7) 29.7 16.0 15.6 17.7 13.6 15.1 15.8 18.8 16.9 8.8 0.0 0.0
GalT (23) 2535.6 9.7 7.5 5.6 8.4 5.7 10.6 7.1 8.6 13.7 8.6 8.0
SiaT (0.5) 1.6 1.5 1.5 1.6 1.6 1.5 1.5 1.3 6.4 1.4 1.3 1.3
Glycan (gi) Glycan % of Glycoform Profile
a
g20 (9.7) 96.3 0.7 1 0.3 0.7 1.1 1.2 0.9 3.7 0.8 0 0
g26 (5.0) 2 99.3 1.2 0 4.4 1.7 2.4 0.7 0 0 0 0
g43 (8.9) 0.1 0 97.8 0 0 17.1 0 0 1.1 0.9 0 0
g50 (6.3) 0 0 0 94.3 13.1 8.2 0 7.3 0 1.9 0 0
g67 (15.7) 0 0 0 2.9 81.4 18.7 0 9.6 0 12.4 0 0
g99 (3.7) 0 0 0 0 0 53.3 0 0 0 7.1 0 0
g157 (9.5) 1.6 0 0 0 0 0 96.3 5.9 1.0 0.6 0 0
g168 (10.6) 0 0 0 0.1 0 0 0 75.3 0 8.9 0 0
g234 (14.2) 0.1 0 0 0 0 0 0 0 94.2 12 0 0
g315 (6.4) 0 0 0 0 0 0 0 0 0 53.8 0 0
g325 (0.8) 0 0 0 0 0 0 0 0 0 0 100 0.1
g336 (7.5) 0 0 0 2.5 0.4 0 0 0.4 0 1.7 0 99.9
aParentheses denote the basecase simulation values for the enzyme concentrations, and glycan %’s.
doi:10.1371/journal.pone.0000713.t004
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PLoS ONE | www.plosone.org 10 August 2007 | Issue 8 | e713observed experimentally often include those from early (high
mannose type), to intermediate, and terminally processed glycans
[41]. A possible mechanism leading to the emergence of early
glycans in the secreted product is through a distribution of
residence times of glycans caused by mixing in the compartments
of the Golgi. As envisioned in the vesicular transport model, the
glycoprotein cargo in a particular compartment is enclosed in
transport vesicles and transferred to the next compartment
downstream. The 4CSTR model assumes that the protein
molecules in each compartment are well-mixed and all molecules
have equal probability of being engulfed in the transport vesicle,
which is certainly an idealized case. The transport between
compartments is only downstream, that is, the retrograde trans-
port was again assumed to be negligible. Only glycans in the last
compartment (TGN) are allowed to be secreted from the system as
final products. The parameters used were the basecase values
shown in Tables 2 and 3, with the same enzyme localization as the
4PFR simulations.
Of the 12 terminally processed glycans, some have a shorter
reaction path leading to their formation (‘‘early’’ terminal N-
glycans) whereas others have a longer reaction path (‘‘late’’
terminal N-glycans). The positions of these two different terminal
glycan types on the reaction network are highlighted in Figure 1B.
The steady-state terminal glycan distribution in the secreted
product evaluated using the 4CSTR model is shown in Figure 11A,
and compared to the results from the 4PFR model with
a 40 minute holding time. The 4CSTR model showed a decrease
in the early terminal glycans, including glycan 20 and an increase
in the late terminal glycans. The secretion rates for the non-
terminally processed N-glycan products obtained in the 4PFR and
4CSTR systems are shown as heat maps in Figure 11C. The rate
of secretion of each glycan is depicted by the color of the
corresponding line segment. With the long holding time that was
used, the glycoform profile change of terminal and non-terminal
glycans are not very profound with the parameter values used for
simulation. It thus appears that the effect of changing from a 4PFR
to a 4CSTR system is much less dramatic than the case of
changing from the 1PFR to the 4PFR model with a spatial enzyme
distribution (Fig. 10). However, if indeed each compartment
resembles a CSTR, glycans will have a wide distribution of holding
times when exiting to the next compartment. It will certainly result
in an increased heterogeneity in the last compartment and thus in
the secreted product. With a sufficiently long holding time the
non-terminal glycans constitute only a small fraction of total
glycans. In the case that the holding time is shorter, an increased
heterogeneity, with a higher presence of intermediate glycans is
certainly expected. We examined the case in which the residence
time of glycans was set at 20 minutes (5 minutes in each
compartment) and the results are shown in Figures 11B and
11D. In this case the contrast between 4PFR and 4CSTR is even
more vivid. As expected, the fluxes of the terminal glycans are
reduced from those attained at the 40 minute residence time, but
the decrease is more profound with 4PFR than with 4CSTR
(Fig. 11B). These glycans in the 4PFR system appear as high
mannose glycans because of insufficient reaction time in the early
compartments. The glycans which do not get processed in the
early compartment will not get extended in the downstream
compartments if the required enzymes are not sufficiently localized
in the downstream compartments. A closer examination of the
composition of the non-terminal glycans reveals that except for the
very least processed N-glycans, the early and late intermediate N-
glycans are present at higher levels in the 4CSTR system, and are
more heterogeneous (Fig. 11D). This is expected in a mixing
reactor system.
Channeling Of Fluxes to Produce Homogeneous
Glycoform Profiles
The 4PFR model simulation results points to how high mannose
glycans can become a rather significant fraction of the product
glycans as has been reported [41]. A contributing factor towards
this phenomenon is through enzyme localization; the responsible
enzymes are present in abundance only in the early compartment,
the unreacted glycans thus remain unprocessed and are secreted
with the other more fully processed N-glycans. The 4PFR model
does predict a high proportion of very early glycans. The 4PFR
model also simultaneously predicts the presence of a smaller
number of intermediate glycans at a significant level; whereas the
4CSTR model favors a wider spectrum of intermediate glycans.
The reported glycoform profiles tend to show a number of
significantly abundant glycans, rather than having a larger number
of insignificantly abundant glycans.
To assess whether glycans on a glycoprotein can be directed to
become ‘‘uniform’’ we applied the non-linear optimization
algorithm to vary the spatial distribution of enzymes. The
objective function was set to channel the fluxes in the 4PFR
model towards glycan 99, a triantennary glycan with a bisecting
N-acetylglucosamine. In the 1PFR model this glycan could not be
produced as a homogeneous product through the manipulation of
enzyme levels alone (Table 4). We thus chose this glycan to
illustrate that through spatial enzyme localization, it can be
secreted theoretically as a uniform product. The enzymes levels in
Figure 10. Comparison of N-glycan fluxes between 1PFR and 4PFR models. A: Terminal glycan fluxes. B: Nonterminal glycan fluxes.
doi:10.1371/journal.pone.0000713.g010
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PLoS ONE | www.plosone.org 11 August 2007 | Issue 8 | e713each compartment that facilitate the formation of uniform glycan
99 are listed in Table 5. Not every enzyme is present in every
compartment. Due to the glycan substrate distribution in each
compartment only a fraction of the possible reactions for each
enzyme have an active flux in each compartment. For example
comparing GnT V in the medial cisternae and all the reactions it
catalyses (Fig. 3), only a small fraction is active. Similar
applications of the nonlinear optimization algorithm towards
varying the spatial enzyme distribution for achieving uniformity of
the other terminal N-glycans was also successful. Hence, both
enzyme concentration and localization are important towards the
redistribution of fluxes through the N-glycan biosynthetic
pathway.
The 10 enzymes considered can be classified into three
categories for each compartment. Category I enzymes are those
which are essential for channeling glycans to the homogenous end
product, category II enzymes are those whose presence in the
compartment is neither essential nor detrimental, category III
enzymes are detrimental and cause divergence of fluxes and
preclude the formation of glycan homogeneity. A number of
enzymes in particular compartments are category II; their
concentrations in those compartments can be from zero to very
high without any consequence on the glycan flux profile. For
clarity, the concentrations of category II enzymes in those
particular compartments are kept at zero. The entries in Table 5
are labeled depending upon the category of the enzyme in each
Figure 11. Comparison of N-glycan fluxes between 4PFR and 4CSTR models. A: Terminal glycan fluxes with a 40 min residence time. B: Terminal
glycan fluxes with a 20 min residence time. C: Nonterminal glycan fluxes with a 40 min residence time; least, early, and late processed glycans as
shown in Figure 1B. D: Nonterminal glycan fluxes with a 20 min residence time; least, early, and late processed glycans as shown in Figure 1B.
doi:10.1371/journal.pone.0000713.g011
N-Glycan Processing
PLoS ONE | www.plosone.org 12 August 2007 | Issue 8 | e713compartment. A pictorial representation for the distribution of
enzymes in the four compartments is also presented in Figure 12
with enzymes in categories I, II and III, shown in blue, grey, and
red background respectively. Those reactions which are active
(have positive flux) are depicted by thicker, colored edges,
corresponding to the type of enzyme responsible for the reaction.
Although only the results for glycan 99 are shown, all the other
terminal N-glycans could be made to a uniform product given
a sufficient holding time and enzyme localization (data not shown).
Controlling the order of monosaccharide addition onto the N-
glycan, while simultaneously taking advantage of enzyme substrate
specificities, facilitates the formation of a less heterogeneous
glycoform profile. Experimentally to accomplish the channeling of
fluxes towards a homogeneous product may entail localizing
category I enzymes in the designated compartments, while
simultaneously suppressing category III enzymes in the same
compartment. In the case of glycan 99, enzymes Man I, Man II,
GnT I, GnT II, GnT V, FucT, SiaT fall into either category I or
category II for different compartments. GnT III is a category III
enzyme for the medial but falls into category I for the trans
compartment. Similarly GalT is a category III enzyme for both
the medial and trans compartments, but is an essential enzyme for
the final compartment. In the case of GnT IV, even though it
doesn’t participate in the synthesis of glycan 99, its presence in the
medial or trans compartments increases the heterogeneity in the
end product, and diverts fluxes away from the glycan.
DISCUSSION
Microheterogeneity of N-glycans is ubiquitously seen in mamma-
lian cell derived recombinant glycoproteins. Since glycan micro-
heterogeneity is a natural phenomenon seen even in glycoproteins
in the body, its occurrence per does not pose a concern for
therapeutic proteins. However, different glycoforms of therapeutic
proteins may affect the pharmacokinetic behavior and the activity
of the protein therapeutic. As a result, controlling the micro-
heterogeneity to be within a defined quality range, or even
directing the glycan synthesis to the most effective forms is highly
desirable. Most glycan intermediates involved in the reaction
system can serve as a substrate for multiple enzymes. The ten
enzymes considered unequally share 329 glycan substrates. Such
extensive competition for these glycan substrates by different
enzymes gives the reaction network the look of an intricate web
with multiple branches. Rationally engineering the pathway to
channel the fluxes towards a preferred glycan may not be an easy
task without the aid of careful analysis. In this study we examined
a number of factors contributing to heterogeneous glycan
distribution.
We analyzed the glycosylation reactions at two levels. First the
reactions were simulated in a single plug flow reactor to examine
the intrinsic reaction kinetics; then we proceeded to examine their
behavior in a simulated Golgi apparatus, considering it to be 4PFR
in series or 4CSTR in series. The two models resemble the two
hypotheses on cargo movement across the Golgi; the cisternal
maturation and vesicular transport models.
The reaction paths and reaction time to form fully processed N-
glycans makes the residence time of the glycoprotein in the Golgi
apparatus an important variable. Given a sufficiently long reaction
time, all glycan reactants in the input will be converted to fully
processed glycans, as can be seen in Figure 5. To reduce the
complexity we chose to use a long residence time for most analyses
presented. This residence time is within the range of values reported
in the Golgi [42]. Furthermore, to observe the flux distribution of all
branches involved, the parameter values were adjusted from those
obtained from literature to allow for fluxes of the twelve fully
processed glycans fall within the same order of magnitude. The
highly interactive nature of the network makes the rates of reactions
highly dependent on one another. Not only do the reactions in the
same branch, or in the local region of network affect each other, but
also those in different branches or at different distances in the
network (Fig. 3). No single enzyme plays a dominating role in
channeling the flux to a particular terminal glycan as illustrated by
the distributive nature of thesensitivitycoefficients(Fig.7).Changing
the levels of most enzymes, except SiaT, affects the flux at multiple
branches. The difficulty of channeling glycan fluxes by simply
manipulating a single enzyme level is illustrated by the example of
amplifying GalT as shown in Figure 8. To effectively channel the
glycans one may have to resort to changing the levels of multiple
enzymes depending on the target glycan. As shown in Table 4,
effective channeling towards relative glycan abundance can be
accomplished with many of the terminal N-glycans, but not all.
Since the Golgi is compartmentalized, and is generally thought
as having multiple cisternae, it is prudent to examine the
glycosylation reactions as such. The Golgi maturation model
envisions the Golgi compartments as maturing from early to late
cisternae, with its internal content (including enzymes) evolving
throughout the maturation process. This time evolution can be
viewed as spatial progress over time, just like a plug-flow reactor.
We modeled this system as four tubular reactors in series allowing
Table 5. Enzyme concentrations and their relative distribution
and category in each compartment required to achieve a high
proportion of terminal N-glycan 99.
......................................................................
Enzyme (em) Cem (mM) Enzyme Fold
a
cis medial trans TGN
Man I 29.7 0.8 (I) 0 (II) 0 (II) 0 (II)
Man II 1.4 0 (II) 0.8 (I) 0 (II) 0 (II)
GnT I 1.2 0 (II) 0.8 (I) 0 (II) 0 (II)
GnT II 1.4 0 (II) 0.8 (I) 0 (II) 0 (II)
GnT III 2.9 0 (II) 0 (III) 1.6 (I) 0 (II)
GnT IV 8.6 0 (II) 0 (III) 0 (III) 0 (II)
GnT V 0.9 0 (II) 2.4 (I) 0 (II) 0 (II)
FucT 1.7 0 (II) 1.5 (I) 0 (II) 0 (II)
GalT 23 0 (II) 0 (III) 0 (III) 3.0 (I)
SiaT 0.5 0 (II) 0 (II) 0 (II) 0.8 (I)
Terminal Glycan (gi) Flux (mmol/min)610
15 % of Glycans
20 0 0
26 0 0
43 0 0
50 0 0
67 0 0
99 18.51 100
157 0 0
168 0 0
234 0 0
315 0 0
325 0 0
336 0 0
aParentheses denote the category of each enzyme in each of the
compartments.
doi:10.1371/journal.pone.0000713.t005
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PLoS ONE | www.plosone.org 13 August 2007 | Issue 8 | e713the enzyme concentration to vary in each compartment. An
obvious effect of extending from 1PFR to 4PFR is the presence of
non-terminal N-glycans in the final product. The holding time
used for simulation was more than sufficient for completion of
reaction to terminal glycans in a single PFR, nevertheless
a substantial amount of non-terminal glycans are seen. The
disappearance of early enzymes as the Golgi becomes mature
prevents some intermediately processed glycans from achieving
terminal processing.
A deviation from plug flow can potentially increase the extent of
microheterogeneity since different glycoprotein molecules stay in
each compartment for different lengths of time. Indeed, the
phenomenon of residence time distribution of secreted protein
molecules from the Golgi has been reported [42]. The vesicular
transport model is described as 4 CSTR’s in series. In other words,
the content in each compartment is well-mixed, and the content
that the vesicles carry is identical to the compartment they bud off
from. The time that a protein molecule spends inside the ER,
Golgi, and in the secretory pathway before being secreted varies
with the nature of the molecule, ranging from 28 minutes for a1-
protease inhibitor to over two hours for transferrin [43].
Furthermore, for a given protein not all of its molecules spend
Figure 12. Active and divergent reactions in each compartment for the generation of uniform glycan 99. A: Cis Golgi, B: Medial Golgi, C: Trans
Golgi, D: TGN Golgi. Arrows: blue for reactions with active flux; gray for inactive fluxes; red for divergent fluxes.
doi:10.1371/journal.pone.0000713.g012
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PLoS ONE | www.plosone.org 14 August 2007 | Issue 8 | e713an equal amount of time traversing through those organelles.
Rather, a wide distribution of residence time is seen. This certainly
points to a mechanism of secretory transport that is different from
an ideal plug flow model.
By modeling the Golgi apparatus as 4 CSTR’s in series the
heterogeneity in intermediately processed glycans does increase at
a shorter residence time as compared to 4PFR in series. (Fig. 11)
More species of non-terminal glycans are present if the compart-
ments are treated as a CSTR. As expected, with a very long
holding (or reaction) time, more glycans are terminally processed,
and the degree of heterogeneity is less.
The simulation of glycan distribution is by no means sufficient
to support one model over the other. The true model is likely
neither perfect PFR nor perfect CSTR, but a composite between
them. Indeed, this has been hypothesized previously [6,44].
Nevertheless, taken together the simulation results appear to favor
the maturation model which simulates the process as four tubular
flow reactors in series. As seen in Figure 11D, with a shorter
holding time, the difference between the two models is very
profound. Many early glycans appear in the secreted glycoprotein
products in both the 4CSTR and 4PFR models. In the 4CSTR
system the emergence of early glycans is accompanied by many
other glycans. However, in the 4PFR model the early glycans can
possibly appear as more significant quantities due to enzyme
localization. The emergence of those early glycans resembles
experimental observation with both intracellular and secreted N-
glycans. Indeed, previous studies have shown an abundance of
intracellular high mannose glycans [14,45].
Although the 4PFR model predicts a glycan distribution that
more closely mimics experimental observation, there are other
possible mechanisms which may contribute to the degree of N-
glycan microheterogeneity. For example a sorting mechanism may
selectively allow cargo to move to the next compartment; thus
creating different holding times for different glycan species. The
mixing of the enzymes within the compartments may not be best
depicted as either perfectly well-mixed or plug flow. The Golgi
glycosylation enzymes are all type II transmembrane proteins
consisting of an amino terminal cytoplasmic tail, a signal anchor
transmembrane domain, a stem region, and a large luminal
catalytic domain. Although the proteins being glycosylated are in
the lumen of the Golgi, the reactions being catalyzed are on the
membranes. As protein substrates travel towards and away from
the glycosylation enzymes on the membrane, some degree of
micromixing is inevitable.
Another key assumption which may have a major effect on
microheterogeneity is the relative specificity of the enzymes toward
their various substrates. In our model the affinities are assumed to
be the same for all glycan substrates for each enzyme. Previous
reports have shown that these binding constants are different in
some cases [46]. The fact that reported glycans are not as
heterogeneous as the above simulations may indicate that
substrate affinity may have a prominent role. Unfortunately
experimental data on substrate specificity is extremely difficult to
obtain, and the literature information is incomplete. With
sufficient glycan data one may deduce the relative affinity of
different glycans towards the same enzymes.
In this report we notably did not address the issue of the effect of
productivity. Of course, the effect of protein secretion rate on its
glycan microheterogeneity is of paramount interest for bioproces-
sing. One should be reminded that a very large fraction of cellular
proteins traverse through the ER and Golgi, in addition to the
recombinant protein. The glycosylation machinery, at any given
moment, is not only processing glycans on recombinant protein
molecules, but also all the other cellular proteins that pass through
the Golgi. Strictly speaking, in the kinetic equations an expression
of other proteins and their associated glycans ought to be included
as competing substrates. The mechanism of high specific pro-
ductivity is not well-understood. Whether the increased pro-
ductivity is accompanied by a shorter holding time in the Golgi
while maintaining the same Golgi volume, or by an increase in
Golgi volume while maintaining the holding time, is not clear.
Without a better understanding of the mechanism of increased
specific productivity, one cannot rationally predict its effect on the
glycoform distribution.
The order at which the enzymes react upon the N-glycan helps
determine the preferential channeling of the biosynthetic pathways
towards the product glycans. The results shown in Figure 12 and
Table 5 certainly illustrate the potential benefit of spatial
localization in engineering glycoforms and producing a uniform
N-glycan product. In recent years there have been numerous
reports on the effect of glycans on the activities of therapeutic
proteins and on the attempts to engineer the glycan toward the
preferred glycoform.[35,47–49]. There has also been an increased
interest in producing glycoproteins of ‘‘uniform’’ glycan compo-
sition, especially by production in yeast [50]. The interest is
spurred not only by the possibility of more comprehensively
examining such molecules’ biological activities, but also by its
potential applications in better formulating biotherapeutic pro-
teins. The mechanism of localization of glycosylation enzymes to
different Golgi compartments is still not well-understood. In the
vesicular transport model the enzymes are effectively retained in
different relative abundances within the cisternae while the cargo
is transported through vesicles (for review [51]). Whereas in the
Golgi maturation model, the cargo stays in the cisternae as it
matures through the secretory pathway. The protein structure
requisite for functional retention within the respective cisternae has
been studied, and has been found to differ between different protein
glycosylation enzymes [52]. Engineering enzyme localization has
been successfully used in Pichia pastoris towards the generation of
uniform, and humanized glycoform profiles [50,53]. Changing the
localization of glycosylation enzyme GnT III has been attempted in
mammalian cells [54], which resulted in an increase in the
proportion of GlcNAc bisected, non-fucosylated, hybrid-type
glycans. This work certainly points to the feasibility of engineering
the glycosylation pathway through enzyme localization.
It should also be noted that a large number of proteins transit
through the Golgi in addition to the recombinant protein product.
Drastically altering the glycosylation pathway may also alter the
glycan structure or protein quality of other cellular proteins.
Channeling N-glycans to a uniform glycoform thus requires not
only information on protein localization, but also a better un-
derstanding of the effect of glycan modification on cellular
homeostasis. For further exploration of cellular engineering and
modulating glycan microheterogeneity one should explore the
engineering of enzymatic substrate specificity to direct the N-glycans
toward desirable pathways in addition to altering their localization.
The model developed in this study can be used to further the
exploration of an optimal way of modulating enzymatic substrate
specificity in order to alleviate and/or improve N-glycan micro-
heterogeneity towards a desired glycoform profile. Such a systematic
approachwill continuetoenhanceour capability inglycoengineering.
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